Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • APLD vs GSK✓SelectedUSD · GSKAPLD vs GSK performance historyLatest closeAs of-8.70%11/16
Stock and ETF performance explorer

APLD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+200.6%
GSK return
+29.9%
Excess return
+170.7%
Maximum drawdown
-81.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.7%-0.1%-8.6%-8.7%
7D-12.8%-1.3%-11.5%-12.6%
30D-19.2%+2.7%-22.0%-19.8%
3M-53.3%+2.7%-56.0%-53.8%
6M-65.7%+3.3%-69.1%-66.5%
YTD-40.5%+6.5%-47.0%-42.9%
1Y-38.4%+10.7%-49.0%-41.9%
3Y+240.7%+64.4%+176.3%+113.4%
All+200.6%+29.9%+170.7%+270.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling